Boston Harbor Angels — 2018 Investments
3 investments dated 2018 · listed companies and verified rows first · show all
Landsdowne Labs develops button battery technology that deactivates batteries after accidental ingestion to address health risks.
Deep TechHealthtechMedical DevicesNew MaterialsStamford, US
Jeffrey Karp(Executive Officer, Promoter)Robert Langer(Director, Promoter)Bryan Laulicht(Executive Officer, Promoter)Melissa Fensterstock(Executive Officer, Director, Promoter)
BoardDaniel Goldberg(Director)Patrick O'Neill(Director)
Co-investorsConnecticut InnovationsHBS Angels of Boston
HealthtechLowell, US
BRIAN HESS(Executive Officer, Director)D. GRAYSON ALLEN(Executive Officer, Director)
BoardKEVIN FOLEY(Director)GEORGE KAY(Director)
Siamab Therapeutics is a biopharmaceutical company developing therapeutic antibodies that target tumor-associated carbohydrate antigens (glycans) found on solid tumors such as ovarian, pancreatic, prostate, colon, and breast cancers.
BiotechHealthtechNewton, US
Jeffrey Behrens(Executive Officer, Director)Ajit Varki(Director)Sundar Subramaniam(Executive Officer, Director)
BoardRobert Mashal(Director)Brad Curley(Director)Gary Pforzheimer(Director)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.